Bayesian Capital Management’s Annexon ANNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,099
Closed -$131K 675
2024
Q3
$131K Sell
22,099
-16,500
-43% -$97.8K 0.02% 592
2024
Q2
$189K Buy
38,599
+22,000
+133% +$114K 0.02% 612
2024
Q1
$119K Buy
+16,599
New +$86.2K 0.01% 705
2023
Q3
Sell
-21,230
Closed -$74.7K 684
2023
Q2
$74.7K Buy
+21,230
New +$92.8K 0.01% 709

Other funds holding ANNX

Bayesian Capital Management's ANNX Position: Q4 2024 in Review

Bayesian Capital Management sold out of Annexon (ANNX) in Q4 2024, closing a stake of 22,099 shares — an estimated $131K sold.

Bayesian Capital Management first reported a position in ANNX in Q2 2023 and held it in 4 quarters. The position peaked at $189K in Q2 2024. 152 funds tracked by Wall St. Rank hold ANNX as of Q4 2024.

  • Bayesian Capital Management reported no remaining Annexon position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 22,099 Annexon shares in Q4 2024, an estimated $131K.
  • Bayesian Capital Management first reported a position in Annexon in Q2 2023 and held it in 4 quarters.
  • Bayesian Capital Management's Annexon position peaked at $189K in Q2 2024.
  • 152 funds tracked by Wall St. Rank held Annexon as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.